Tang Lin, a former director-level cadre of the Higher People's Court of Guizhou Province, held a trial in the first instance. On December 12, 2024, the Intermediate People's Court of tongren city, Guizhou Province held a trial in the first instance to hear the case of Tang Lin, a former director-level cadre of the Higher People's Court of Guizhou Province. Tongren city People's Procuratorate prosecuted the charges: During 2012-2023, defendant Tang Lin took advantage of his position as President of Liupanshui Intermediate People's Court, Vice President of Guizhou Higher People's Court, Director of Legal Affairs Office of Guizhou Provincial People's Government, Executive Vice President of Guizhou Higher People's Court, and the convenience of his authority and position to help relevant units and individuals in handling cases, and illegally accepted other people's property totaling RMB 21.47 million. From December 2007 to January 2011, Tang Lin took advantage of his position as the president of Liupanshui Intermediate People's Court to facilitate the illegal possession of public property with others, totaling RMB 660,000, of which RMB 330,000 was shared by individuals. The public prosecution agency requested Tang Lin to be investigated for criminal responsibility for accepting bribes and corruption. (Dynamic and static Guizhou)In the latest centralized purchase of sitagliptin tablets, the price dropped to less than 20 cents per tablet, with a drop of over 90%. The reporter learned at the scene of the tenth batch of drug centralized purchase that more than 30 companies bid for sitagliptin, which is known as the largest variety in this centralized purchase, including Huahai Pharmaceutical, Kelun Pharmaceutical, Zhengda Tianqing, tonghua dongbao, Zhejiang Pharmaceutical, Jiudian Pharmaceutical, Shiyao Ouyi, Chenxin Pharmaceutical and many other companies. Judging from the bidding results, the lowest bid price among enterprises has dropped below 0.2 yuan per piece, which is more than 90% lower than the limit price. Statistics show that in 2023, the sales of this product in the terminals of public medical institutions in China exceeded 2 billion yuan, and the sales of Merck, the original research manufacturer, accounted for more than 90%, so there is a large room for the replacement of generic drugs. The quotation of Meradong in this collection is about 7.37 yuan per piece. (science and technology innovation board Daily)Guangxi: In November, 23,774 cases of legal infectious diseases were reported and 320 people died. The Health and Health Commission of Guangxi Zhuang Autonomous Region announced the epidemic situation of legal infectious diseases in Guangxi in November 2024. No cases of Class A infectious diseases were reported. 14,775 cases of Class B infectious diseases were reported, with 320 deaths. The reported diseases include AIDS, viral hepatitis, rabies, dengue fever, dysentery, tuberculosis, typhoid plus paratyphoid, whooping cough, scarlet fever, brucellosis, gonorrhea, syphilis, leptospirosis, malaria, novel coronavirus infection and monkeypox. The top five reported cases were viral hepatitis, tuberculosis, syphilis, AIDS and gonorrhea, accounting for 94.34% in total. 8999 cases of Class C infectious diseases were reported, with no death. The reported diseases include influenza, mumps, rubella, acute hemorrhagic conjunctivitis, leprosy, typhus, other infectious diarrhea and hand, foot and mouth disease. The top three reported cases were other infectious diarrhea, hand-foot-mouth disease and influenza, accounting for 91.43% in total.
The Israeli army launched several rounds of air strikes on many places in Gaza, resulting in 37 deaths. On December 12, local time, the reporter of the General Station was informed that the Israeli army launched several rounds of air strikes on Gaza City in the north, Nuseilet refugee camp in the middle and Khan Younis in the south of the Gaza since the early morning of that day, which has caused 37 deaths. At present, the Israeli side has not issued a statement on related events. (CCTV News)Jilin: Set up an investment fund of 1 billion yuan to guide the ice and snow industry. According to the news of "Jilin Publishing" WeChat WeChat official account on December 12, recently, the General Office of Jilin Provincial Party Committee and the General Office of the provincial government issued the "Implementation Opinions on Promoting the High-quality Development of Ice and Snow Economy in Jilin Province". Sun Guangzhi, director of Jilin Provincial Department of Culture and Tourism, said that the "Implementation Opinions" focused on the ice and snow equipment industry. Industry-University-Research will be promoted to tackle key problems through collaboration, and breakthroughs will be made in key technologies of ice and snow. Build an ice and snow equipment industrial park, introduce advanced ice and snow equipment projects, and improve the ice and snow equipment industrial chain in Jilin Province. Through "one-on-one" accurate counseling, we will cultivate "specialized and innovative" enterprises of ice and snow equipment. Plan to set up large-scale ice and snow equipment maintenance companies such as ropeways, cable cars and snow presses to provide market-oriented services for snow rinks and ice rinks. Focus on improving the security system of ice and snow economic factors. Relying on the universities in the province, we will build 10 first-class majors such as ice and snow sports and ice and snow economy, build 10 modern industrial colleges in the field of ice and snow, and build a perfect training system for ice and snow professionals. Increase financial support, set up an investment fund of 1 billion yuan to guide the ice and snow industry, and co-ordinate various financial funds to support the ice and snow economy of 500 million yuan. Establish a financial aid mechanism to guide social capital to invest in ice and snow projects. Innovate industrial support policies and strengthen the protection of factors such as land for ice and snow projects.Anhui's first high-growth industrial bond was successfully issued in Shanghai. Recently, Anhui Wantong Expressway Co., Ltd. (referred to as "Wantong Expressway") completed the issuance of Anhui's first high-growth industrial bond in Shanghai Stock Exchange. On October 30th this year, Wan Tong Expressway was approved by China Securities Regulatory Commission to publicly issue corporate bonds with a registered scale of no more than 5 billion yuan to professional investors.
For the first time, Nanjing Port docked with container ships of "longest ship scale" and "maximum load". Today (December 12th) morning, the largest container ship that entered the port since the opening of Nanjing Port, Panamanian vessel "Mai Di Hong Wei", successfully docked at Longtan Container Terminal, setting a new "double historical record" for the longest scale and maximum load of container ships entering the port. It is understood that the ship is 208.3 meters long, 29.8 meters wide and 33,715 tons deadweight. This voyage is a direct flight from Europe to Nanjing, which will directly increase the maximum container capacity of incoming ships from the current 1938TEU (standard container) to 2600TEU. The successful berthing indicates that 30,000-ton container ships can enter and leave Nanjing Port normally. (CCTV News)South Korea's National Assembly passed "Yin Xiyue's General Special Inspection Law" and "Jin Jianxit's Inspection Law". The reporter of the General Station was informed that on the 12th local time, South Korea's National Assembly held a general meeting of parliamentarians and passed "Yin Xiyue's General Special Inspection Law" and "Jin Jianxit's Inspection Law". (CCTV News)In the latest centralized purchase of sitagliptin tablets, the price dropped to less than 20 cents per tablet, with a drop of over 90%. The reporter learned at the scene of the tenth batch of drug centralized purchase that more than 30 companies bid for sitagliptin, which is known as the largest variety in this centralized purchase, including Huahai Pharmaceutical, Kelun Pharmaceutical, Zhengda Tianqing, tonghua dongbao, Zhejiang Pharmaceutical, Jiudian Pharmaceutical, Shiyao Ouyi, Chenxin Pharmaceutical and many other companies. Judging from the bidding results, the lowest bid price among enterprises has dropped below 0.2 yuan per piece, which is more than 90% lower than the limit price. Statistics show that in 2023, the sales of this product in the terminals of public medical institutions in China exceeded 2 billion yuan, and the sales of Merck, the original research manufacturer, accounted for more than 90%, so there is a large room for the replacement of generic drugs. The quotation of Meradong in this collection is about 7.37 yuan per piece. (science and technology innovation board Daily)
Strategy guide
12-13
Strategy guide 12-13